This is a Cigna news story, published by CNBC, that relates primarily to Omada Health news.
For more Cigna news, you can click here:
more Cigna newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from CNBC, you can click here:
more news from CNBCOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Startup Virta Health. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest weight loss enrollees news, Evernorth pharmacy benefits division news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Virta Health founderCNBC
•
81% Informative
Employers are increasingly requiring workers on GLP-1 medications to enroll in nutrition and lifestyle coaching programs.
Virta Health saw 60% revenue growth last year , topping $100 million .
Rival startup Omada Health partnered with Cigna 's Evernorth division on the EncircleRx program which grew 4-fold to 8 million covered lives.
VR Score
82
Informative language
81
Neutral language
76
Article tone
semi-formal
Language
English
Language complexity
57
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links